## Local Anesthetic Systemic Toxicity (LAST) — Seizure Phase Management ### Clinical Recognition The patient presents with classic prodromal signs of LAST: - **Neurological symptoms:** tinnitus, circumoral numbness, restlessness - **Cardiovascular signs:** hypertension and tachycardia (early phase) - **Progression to seizure** within minutes of symptom onset The spinal dose of 12 mg bupivacaine is within safe limits, but toxicity can occur from inadvertent intravascular injection or rapid systemic absorption. ### Mechanism of LAST **Key Point:** Local anesthetics block sodium channels in the CNS and cardiovascular system. At toxic concentrations, they cause: 1. Initial CNS excitation (seizures, tremor, tinnitus) 2. CNS depression (loss of consciousness, apnea) 3. Cardiovascular collapse (arrhythmias, bradycardia, hypotension) ### Management Algorithm ```mermaid flowchart TD A[Suspected LAST]:::outcome --> B{Seizure present?}:::decision B -->|Yes| C[Stop injection immediately]:::action C --> D[Call for help & lipid emulsion]:::action D --> E[Secure airway, 100% O₂]:::action E --> F[Seizure control: benzodiazepine or propofol]:::action F --> G[20% Lipid Emulsion 1.5 mL/kg bolus]:::action G --> H[Lipid infusion: 0.25 mL/kg/min]:::action H --> I[Repeat bolus q5min if seizure persists]:::action I --> J[Max cumulative dose: 10-12 mL/kg over first 30 min]:::action J --> K[ACLS if cardiac arrest]:::urgent ``` ### Why Lipid Emulsion is First-Line **High-Yield:** The American Society of Regional Anesthesia (ASRA) 2012 guidelines mandate **20% lipid emulsion as the definitive antidote** for LAST, especially in seizure or cardiac arrest phases. **Mechanism of Lipid Rescue:** - Lipid acts as a "lipophilic sink" — it extracts bupivacaine from the CNS and myocardium - Redistributes drug away from effect sites - Restores cardiac contractility and perfusion **Dosing:** - **Initial bolus:** 1.5 mL/kg IV over 1 minute (e.g., 105 mL for 70 kg patient) - **Infusion:** 0.25 mL/kg/min - **Repeat bolus:** every 5–10 minutes if seizure or cardiac instability persists - **Maximum cumulative dose:** 10–12 mL/kg in first 30 minutes ### Concurrent Seizure Management **Clinical Pearl:** While lipid emulsion is being prepared and administered: 1. **Secure airway** with 100% oxygen (prevent hypoxia-induced cardiac arrest) 2. **Stop the injection** immediately 3. **Treat seizure** with benzodiazepine (lorazepam 2–4 mg IV) or small dose propofol (1–2 mg/kg) 4. **Avoid large propofol doses** — propofol itself is lipophilic and may compete with lipid-bupivacaine binding **Warning:** Do NOT rely on seizure medications alone. Lipid emulsion must be initiated without delay. ### Why Lipid Emulsion Over Other Agents | Intervention | Rationale | Outcome | |---|---|---| | **20% Lipid emulsion** | Removes drug from CNS/cardiac tissue | **Definitive reversal** | | Propofol alone | Seizure control only; no drug removal | Temporary; LAST may recur | | Sodium bicarbonate | Useful in bupivacaine-induced cardiac arrhythmias, not seizures | Adjunctive, not primary | | Magnesium sulfate | No proven benefit in LAST | Ineffective | ### Key Timeline **Mnemonic: LAST-LIPID** - **L**ocal anesthetic toxicity → **L**ipid emulsion - **A**irway, **I**ntubation (if needed) - **S**eizure control → **P**ropofol or benzodiazepine - **T**reatment → **I**nfusion (0.25 mL/kg/min) - **D**ose: 1.5 mL/kg bolus, repeat q5 min **High-Yield:** Lipid emulsion should be available in every operating room and labor ward where regional anesthesia is performed. Time to administration is critical — delays worsen outcomes. [cite:ASRA Guidelines 2012 on Local Anesthetic Systemic Toxicity] [cite:Miller's Anesthesia 8e Ch 16]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.